Disease Returns to Second Child “Cured” of HIV

Like the Mississippi child that was thought to have beaten HIV after aggressive anti-retroviral treatment, detectable levels of the virus return in an Italian child who received similar therapy.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Scanning electromicrograph of an HIV-infected T cellWIKIMEDIA, NIAIDHIV has reappeared in an Italian toddler who received early and aggressive anti-retroviral treatments, after which doctors thought they had eradicated the virus, according to a report published Saturday (October 4) in The Lancet. The case echoes findings that came to light earlier this year regarding a young girl in Mississippi whose HIV infection returned after the virus had been absent from her body for about four years. She, too, had been given anti-retroviral treatment soon after birth. The treatments were stopped in both children, who were born HIV positive, after the virus stopped turning up in detectable levels in their blood.

“Although there are a large number of antiviral medications to control HIV, a cure hasn’t been found,” Sanjaya Senanayake, an infectious diseases physician at the Australian National University Medical School in Canberra who did not treat either child, told The Guardian. “At the time of stopping the antiviral medicines, the child’s immune system was still responding as if HIV was present even though the virus was undetectable. And within two weeks of stopping treatment, the virus became detectable again. This case shows that undetectable HIV in the blood does not mean that the body is free from virus and that there is still some way to go before a cure is found.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies